# China NMPA Drug Inspection - Guangxi Shengte Pharmaceutical Co., Ltd. - Isatis root granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangxi-shengte-pharmaceutical-co-ltd/9365314b-42e5-4743-b033-cb0f6f7776fd/
Source feed: China

> China NMPA drug inspection for Guangxi Shengte Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Isatis root granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Guangxi Shengte Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Isatis root granules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/guangxi-shengte-pharmaceutical-co-ltd/4dbdff32-5395-4a09-8aef-e61026bd15c9/